Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Lundbeck gets US approval for migraine drug at heart of Alder takeover

US regulator clears CGRP inhibitor under Vyepti trade name

- PMLiVE

BRIC markets

Why these countries offer an opportunity for pharma despite a slowdown

Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story

Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club.

Impetus Digital

Courageous Conversations ep.4: Five Key Benefits of the Internet of Medical Things

Impetus Digital

Courageous Conversations ep.3: Facial Recognition Technology and Its Impact on Healthcare

Impetus Digital

- PMLiVE

Bedrock Group celebrates a trio of new hires

Bedrock Group is gearing up for a year of incredible growth with the hire of two new Strategic Solutions Directors as well as an additional Account Manager.

Bedrock Healthcare Communications

- PMLiVE

Researchers discover new antibiotic using AI

First antibiotic to be discovered using this method

- PMLiVE

Tocagen merges with Forte Biosciences after brain cancer fail

New company will focus on Forte's lead skin disease drug

- PMLiVE

GSK pays $50m upfront to tap Immatics’ cell therapy platform

Deal focuses on T cell receptor therapies

- PMLiVE

Immutep spikes on trial of its LAG-3 drug with Keytruda

Impressive mid-stage results in NSCLC and HNSCC

- PMLiVE

Ex-BMS exec jumps to Gilead to lead research group

Gilead appoints Michael Quigley to lead research team

Digital divergence

Combining digital and pharma is proving less easy than previously thought

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links